Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Launching of EHealth Lebanon Mobile App. for MoPH Digital Services

 
Caretaker Deputy Prime Minister and Health Minister Ghassan Hasbani launched EHealth Lebanon mobile App for the MOPH  digital services. This project is the product of collaboration between the Ministry of Public Health and Loubnaniyoun Association, knowing that the Ministry has not incurred any financial costs. The launching ceremony was attended by the head of the Lebanese Order of Physicians in Beirut Pr. Raymond Sayegh, the Syndicate of Private Hospitals President Suleiman Haroun, the President of the Syndicate of Nurseries in Lebanon Hana Joujou, representatives of Loubnaniyoun Association, Dr. Guy Hokayem, Mrs. Katia Mansour, the National E-health Programme Director Lina Abou Mrad and concerned parties.
 
Abou Mrad opened the launching ceremony by introducing the MOPH’s process of facilitating the administrative procedures back from 2000 to date. In this context, several projects were completed to end up with the digital services. She also mentioned the different strategic initiatives of the Ministry within “Health 2025” Plan, which are: digital complaint reporting, the electronic medical record (EMR), custom registration, Drug barcode system, the One stop Shop, and e-government services.
 
Mrs. Mrad delivered a technical presentation on EHealth Lebanon mobile application, during which she introduced the different digitized services that are available to all the citizens on the digital platform that was developed to this end.
 
Minister Hasbani noted that launching the digital services is considered as a new step in the service of the Lebanese citizen. The role of the Ministry of Public Health encompasses not only the medical services provision, but also the supervision and registration of the medical professions, drug warehouses and the companies that import them. Hasbani added that all the transactions are now electronically available.  
 
 “The implementation of the project will take a long time, since the administrative services will be provided in parallel with the electronic ones for the citizens to get used to the digital services,” noted Hasbani.

“This project aims at keeping up with the evolving human competences of the physicians and medical professions workers”, said Hasbani.
    ...
    115
    ...
ATC Name B/G Ingredients Dosage Form Price
L01FF04 BAVENCIO BioTech Avelumab - 200mg/10ml 200mg/10ml Injectable concentrate for solution L.L
L01FF05 TECENTRIQ BioTech Atezolizumab - 1200mg 1200mg Injectable concentrate for solution 375,054,619 L.L
L01FF05 TECENTRIQ BioTech Atezolizumab - 1200mg 1200mg Injectable concentrate for solution 375,054,619 L.L
L01FF05 TECENTRIQ BioTech Atezolizumab - 1875mg/15ml 1875mg/15ml Injectable solution 375,054,619 L.L
L01FF05 TECENTRIQ BioTech Atezolizumab - 1200mg 1200mg Injectable concentrate for solution L.L
L01FG01 AVASTIN BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable concentrated solution 75,875,312 L.L
L01FG01 AVASTIN BioTech Bevacizumab - 400mg 400mg Injectable concentrated solution 75,875,312 L.L
L01FG01 STIVANT BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable concentrate for solution 27,359,527 L.L
L01FG01 ZIRABEV BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable solution 49,965,229 L.L
L01FG01 MVASI BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable concentrate for solution 58,035,926 L.L
L01FG01 BIVASTINA 400 BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable concentrate for solution 92,353,609 L.L
L01FG01 BEVACIREL BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable solution 49,744,595 L.L
L01FG01 BIVASTINA 400 BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable concentrate for solution 53,111,763 L.L
L01FG01 AVASTIN BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable concentrated solution 24,533,456 L.L
L01FG01 AVASTIN BioTech Bevacizumab - 100mg 100mg Injectable concentrated solution 24,533,456 L.L
L01FG01 STIVANT BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable concentrate for solution 14,719,570 L.L
L01FG01 BIVASTINA 100 BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable concentrate for solution 22,840,337 L.L
L01FG01 BIVASTINA 100 BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable concentrate for solution 12,021,318 L.L
L01FG01 ZIRABEV BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable solution 14,800,115 L.L
L01FG01 MVASI BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable concentrate for solution 17,173,671 L.L
L01FG01 BEVACIREL BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable solution 14,719,570 L.L
L01FG01 BEVACIREL BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable solution L.L
L01FG01 BEVACIREL BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable solution L.L
L01FG02 CYRAMZA BioTech Ramucirumab - 100mg/10ml 100mg/10ml Injectable solution 47,779,251 L.L
L01FG02 CYRAMZA BioTech Ramucirumab - 500mg/50ml 500mg/50ml Injectable solution 218,656,548 L.L
L01FG02 CYRAMZA BioTech Ramucirumab - 500mg/50ml 500mg/50ml Injectable solution L.L
L01FX02 MYLOTARG BioTech Gemtuzumab Ozogamicin - 4.5mg 4.5mg Injectable powder 748,160,090 L.L
L01FX04 YERVOY BioTech Ipilimumab - 50mg/10ml 50mg/10ml Injectable solution 332,262,937 L.L
L01FX04 YERVOY BioTech Ipilimumab - 50mg/10ml 50mg/10ml Injectable solution L.L
L01FX05 ADCETRIS BioTech Brentuximab Vedotin - 50mg 50mg Injectable powder for concentrate for solution 298,266,862 L.L
    ...
    115
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025